Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From BostonGene Corp.
During Q2, biopharmas brought in an aggregate $12.5bn in financing and device company fundraising totaled $3.7bn; while in vitro diagnostic firms and research tools players raised $720m.
The firms hope academic research can yield first-in-class therapies and spinout companies. Also, Yale unveils research alliances with three biotechs.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Artificial Intelligence
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.